Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsis.

Shimamoto Y, Fukuda T, Tanaka K, Komori K, Sadamitsu D.

Intensive Care Med. 2013 Jul;39(7):1247-52. doi: 10.1007/s00134-013-2909-9. Epub 2013 Apr 20.

PMID:
23604132
2.

Change of teicoplanin loading dose requirement for incremental increases of systemic inflammatory response syndrome score in the setting of sepsis.

Nakano T, Nakamura Y, Takata T, Irie K, Sano K, Imakyure O, Mishima K, Futagami K.

Int J Clin Pharm. 2016 Aug;38(4):908-14. doi: 10.1007/s11096-016-0308-3. Epub 2016 Apr 28.

PMID:
27125378
3.
4.

Vancomycin pharmacokinetics in patients with severe burn injuries.

Dolton M, Xu H, Cheong E, Maitz P, Kennedy P, Gottlieb T, Buono E, McLachlan AJ.

Burns. 2010 Jun;36(4):469-76. doi: 10.1016/j.burns.2009.08.010. Epub 2009 Oct 28.

PMID:
19875238
5.

Initial dosage regimens of vancomycin for Chinese adult patients based on population pharmacokinetic analysis.

Deng C, Liu T, Zhou T, Lu H, Cheng D, Zhong X, Lu W.

Int J Clin Pharmacol Ther. 2013 May;51(5):407-15. doi: 10.5414/CP201842.

PMID:
23458230
6.

Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population.

Jarkowski A 3rd, Forrest A, Sweeney RP, Tan W, Segal BH, Almyroudis N, Wang ES, Wetzler M.

J Oncol Pharm Pract. 2012 Mar;18(1):91-6. doi: 10.1177/1078155211402107. Epub 2011 Apr 26.

PMID:
21521799
8.

Population pharmacokinetics of vancomycin in Japanese adult patients.

Yasuhara M, Iga T, Zenda H, Okumura K, Oguma T, Yano Y, Hori R.

Ther Drug Monit. 1998 Apr;20(2):139-48.

PMID:
9558127
9.

Vancomycin dosing in children and young adults: back to the drawing board.

Camaione L, Elliott K, Mitchell-Van Steele A, Lomaestro B, Pai MP.

Pharmacotherapy. 2013 Dec;33(12):1278-87. doi: 10.1002/phar.1345. Epub 2013 Sep 9.

PMID:
24019205
10.

Clearance of vancomycin during continuous infusion in Intensive Care Unit patients: correlation with measured and estimated creatinine clearance and serum cystatin C.

Kees MG, Hilpert JW, Gnewuch C, Kees F, Voegeler S.

Int J Antimicrob Agents. 2010 Dec;36(6):545-8. doi: 10.1016/j.ijantimicag.2010.07.015. Epub 2010 Sep 21.

PMID:
20863668
11.

Decreased vancomycin clearance in patients with congestive heart failure.

Shimamoto Y, Fukuda T, Tominari S, Fukumoto K, Ueno K, Dong M, Tanaka K, Shirasaka T, Komori K.

Eur J Clin Pharmacol. 2013 Mar;69(3):449-57. doi: 10.1007/s00228-012-1340-4. Epub 2012 Jul 12.

PMID:
22791272
12.

Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.

Boereboom FT, Ververs FF, Blankestijn PJ, Savelkoul TJ, van Dijk A.

Intensive Care Med. 1999 Oct;25(10):1100-4.

PMID:
10551965
13.

Vancomycin dosing in neutropenic patients.

Haeseker MB, Croes S, Neef C, Bruggeman CA, Stolk LM, Verbon A.

PLoS One. 2014 Nov 12;9(11):e112008. doi: 10.1371/journal.pone.0112008. eCollection 2014.

14.

A retrospective analysis of vancomycin pharmacokinetics in Japanese cancer and non-cancer patients based on routine trough monitoring data.

Omote S, Yano Y, Hashida T, Masuda S, Yano I, Katsura T, Inui K.

Biol Pharm Bull. 2009 Jan;32(1):99-104.

15.

Effect of various estimates of renal function on prediction of vancomycin concentration by the population mean and Bayesian methods.

Tsuji Y, Hiraki Y, Mizoguchi A, Sadoh S, Sonemoto E, Kamimura H, Karube Y.

J Clin Pharm Ther. 2009 Aug;34(4):465-72. doi: 10.1111/j.1365-2710.2008.01015.x.

PMID:
19583680
16.

Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.

Roberts JA, Lipman J.

Clin Pharmacokinet. 2006;45(8):755-73. Review.

PMID:
16884316
17.

Reduced vancomycin clearance despite unchanged creatinine clearance in patients treated with vancomycin for longer than 4 weeks.

Nakayama H, Echizen H, Tanaka M, Sato M, Orii T.

Ther Drug Monit. 2008 Feb;30(1):103-7. doi: 10.1097/FTD.0b013e318164f781.

PMID:
18223471
18.

Improved vancomycin dosing in children using area under the curve exposure.

Le J, Bradley JS, Murray W, Romanowski GL, Tran TT, Nguyen N, Cho S, Natale S, Bui I, Tran TM, Capparelli EV.

Pediatr Infect Dis J. 2013 Apr;32(4):e155-63. doi: 10.1097/INF.0b013e318286378e.

19.

Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance.

Anderson BJ, Allegaert K, Van den Anker JN, Cossey V, Holford NH.

Br J Clin Pharmacol. 2007 Jan;63(1):75-84. Epub 2006 Jul 21.

20.

Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations.

Thomson AH, Staatz CE, Tobin CM, Gall M, Lovering AM.

J Antimicrob Chemother. 2009 May;63(5):1050-7. doi: 10.1093/jac/dkp085. Epub 2009 Mar 19.

Items per page

Supplemental Content

Write to the Help Desk